What is known?
MRI targeted biopsies are reported to be able to better detect high
grade cancers than systematic biopsies and TRUS. However, several recent
studies have reported a mismatch in the biopsy and radical prostatectomy
Gleason Score. Despite the improved detection of clinically significant
cancers with MRI targeted biopsies, considerable disparity exists in the
literature regarding MRI targeted biopsy’s ability to better detect RP
pathology in biopsy-naive men over conventional TRUS biopsies.